Screener
Potential Milestone Payments Due
Dianthus Therapeutics·Products & Services·3 segments
Breakdown
Segments
First Selected AntibodyView metric
First Development ProgramView metric
Second Development ProgramView metric
| Segment | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| First Selected Antibody | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $11M |
| First Development Program | $3.9M | $3.9M | $4.1M | $3.9M | $4M | $4.3M | $4.2M | $4.1M |
| Second Development Program | $3.2M | $3.2M | $3.3M | $3.1M | $3.2M | $3.4M | $3.4M | $3.3M |
| Total | $11M | $11M | $11M | $11M | $11M | $11M | $11M | $11M |